Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Several factors influence credit card points accumulation. Learn what affects your rewards to enhance your earning potential.
16,561 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
Markets show the U.S. dollar rising as Iran tensions mount, while select crypto assets climb, creating an unusual cro...
Strategy launched its largest BTC sale this week, intensifying the debate over unrealized losses among major crypto h...
A notable AI stock has fallen about 30% this year. This article lays out a practical, battle-tested framework to judg...
As Nasdaq income options proliferate, investors weigh tax treatment and true take-home yields. A clear, current compa...
As April 2026 approaches, investors face AI chatter, geopolitical headlines, and macro uncertainty. This guide offers...
As AI evolves, investors face a choice: a defense-first, multi-year government play or a fast-growing consumer voice ...
Mercer International posts a brutal Q4 hit from impairment, eroding equity, while International Paper pivots to highe...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...